stoxline Quote Chart Rank Option Currency Glossary
  
Akili, Inc. (AKLI)
0.2896  -0 (-0.14%)    03-28 16:00
Open: 0.29
High: 0.305
Volume: 224,518
  
Pre. Close: 0.29
Low: 0.2819
Market Cap: 23(M)
Technical analysis
2024-03-28 4:49:36 PM
Short term     
Mid term     
Targets 6-month :  0.61 1-year :  0.86
Resists First :  0.52 Second :  0.73
Pivot price 0.29
Supports First :  0.19 Second :  0.15
MAs MA(5) :  0.3 MA(20) :  0.3
MA(100) :  0.36 MA(250) :  0.76
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  50.5 D(3) :  54.5
RSI RSI(14): 48.4
52-week High :  1.66 Low :  0.19
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AKLI ] has closed above bottom band by 48.2%. Bollinger Bands are 20.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.31 - 0.31 0.31 - 0.31
Low: 0.28 - 0.28 0.28 - 0.28
Close: 0.29 - 0.29 0.29 - 0.29
Company Description

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

Headline News

Thu, 28 Mar 2024
Akili, Inc. (NASDAQ:AKLI) Short Interest Update - Defense World

Mon, 11 Mar 2024
Akili executive compensation drops in 2023 - Boston Business Journal - The Business Journals

Thu, 29 Feb 2024
Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Yahoo Finance

Tue, 27 Feb 2024
PureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version ... - Business Wire

Mon, 26 Feb 2024
Akili's ADHD device submitted for Japanese approval, stock rallies 130% (NASDAQ:AKLI) - Seeking Alpha

Mon, 26 Feb 2024
Why Is Akili (AKLI) Stock Up 110% Today? - InvestorPlace

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Healthcare - Information Services
Shares Out 0 (M)
Shares Float 79 (M)
Held by Insiders 2.611e+007 (%)
Held by Institutions 23.2 (%)
Shares Short 62 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -6.418e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 551.7 %
Return on Equity (ttm) -35.9 %
Qtrly Rev. Growth 1.68e+006 %
Gross Profit (p.s.) 280.39
Sales Per Share -34.31
EBITDA (p.s.) 0
Qtrly Earnings Growth -0.8 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -58 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 0.79
Stock Dividends
Dividend 0
Forward Dividend 820030
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android